Hearing tech startup Legato launches its AI hearing glasses
Legato, a hearing tech startup, has launched AI hearing glasses intended to make hearing care more accessible by tackling the cost, comfort, and stigma of traditional hearing aids.
How artificial intelligence is applied in medicine — imaging, diagnostics, clinical documentation, drug discovery, and the safety and regulation that come with high stakes.
Legato, a hearing tech startup, has launched AI hearing glasses intended to make hearing care more accessible by tackling the cost, comfort, and stigma of traditional hearing aids.
Microsoft Research unveiled Quine, an early-stage effort to build a multimodal world model of biology that connects insights across biological scales to help scientists prioritize hypotheses before lab testing.
An MIT Technology Review piece explores the question of attributing scientific discoveries to AI, prompted by Anthropic's molecular biology lab where Claude agents propose ideas and human scientists run experiments.
Anthropic reports an early significant finding from its biology lab, and emphasizes that humans remain in the loop rather than letting Claude operate on its own.
Anthropic reports that its Claude AI autonomously identified a new enzyme system similar to Crispr, marking the first result from the company's new wet lab.
Microsoft Research describes RetroChimera, a predictive model for chemical synthesis of small molecules, presented in a Nature paper to help researchers explore more compounds.
TechCrunch reports Anthropic is operating a lab conducting biology experiments, amid AI leaders' promises of curing disease and warnings about AI risks.
A Google AI Blog post describes the company's focus on using advanced AI to accelerate science and help people in areas where it can make meaningful progress.
Microsoft Research presents GigaPath-Flash and GigaTIME-Flash, pathology foundation models that reduce computational demands while maintaining strong performance to enable larger-scale studies.
Bristol Myers Squibb announced it will deploy a second NVIDIA DGX SuperPOD, built on NVIDIA Vera Rubin, to expand one of the largest AI clusters in life sciences.
Drug discovery is the most scientifically credible AI use case — and the one where hype and evidence diverge most. Here is what has actually reached human trials, and what has not.
AI is already assisting in medical imaging and clinical paperwork, but healthcare's stakes demand caution. Here is where it helps today and why human oversight stays central.
AI topics for this sector
Go deeper